Atara Biotherapeutics, Inc. - Common Stock (ATRA)

CUSIP: 046513206

Q2 2025 13F Holders as of 30 Jun 2025

Security identity 2 facts
Security type / class
Equity / Common Stock
Shares outstanding
8,191,888
Holder snapshot 8 facts
Total 13F shares
1,803,350
Share change
-283,443
Total reported value
$13,921,685
Reported price per share
$7.72
Number of holders
32
Value change
-$1,938,164
Number of buys
9
Number of sells
14

Security key

046513206

Report period

Q2 2025

Institutions

32

Top holders

10

ATRA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Atara Biotherapeutics, Inc. SEC filings Atara Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ATRA - Atara Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Adiumentum Capital Fund I LP
13D/G signal
Adiumentum Capital Fund I LP
Evidence rows
15
Latest as of
10 Jun 2025
3/4/5 13D/G 13F Lead comparable stake: 20% 13D/G row: Adiumentum Capital Fund I LP Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Adiumentum Capital Fund I LP
3/4/5 13D/G
Director, Other*, 10%+ Owner
3/4/5 13D/G
20%
from 13D/G
$10,487,308
1,586,588 shares
mixed-class rows
 — 16 May 2025
Redmile Group, LLC
3/4/5 13F
Director · Company
3/4/5 13F
5.4%
$3,356,927
441,701 shares
 — 16 May 2025
Pascal Touchon
3/4/5
Director
3/4/5
0.95%
$589,339
77,955 shares
 — 10 Jun 2025
Carol Giltner Gallagher
3/4/5
Director
3/4/5
0.4%
$249,570
33,012 shares
 — 10 Jun 2025
William K. Heiden
3/4/5
Director
3/4/5
0.27%
$167,741
22,188 shares
 — 10 Jun 2025
Matthew K. Fust
3/4/5
Director
3/4/5
0.22%
$137,501
18,188 shares
 — 10 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
32
Shares
1,803,350
Rows available
32
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
36
Q2 2025 holders
32
Holder diff
-4
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .